Catalog Number MONOVISC, 4 ML, US - 690016 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Hypersensitivity/Allergic reaction (1907); Swelling/ Edema (4577)
|
Event Date 05/11/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
A supplemental report will be submitted upon completion of the plant investigation.
|
|
Event Description
|
On (b)(6) 2021 the fda reported mw 5101289 to (b)(6).The reported event is as follows: patient's orthopedic surgeon injected monovisc into the patients left knee to treat steoarthritis.Five minutes after the injection, the patient experienced swellin and edema in the lips and throat.The patient took benadryl and the symptoms were resolved.Additional information was solicited.
|
|
Manufacturer Narrative
|
The reported event is not confirmed.Additional information was not provided upon solicitation.The lot number is unknown.A review of the batch record could not be performed.A supplemental report will be submitted upon receipt of new and relevant information.This event will be monitored for trending.
|
|
Event Description
|
On 27 may 2021, the fda reported to mw5101289 anika.The reported event is as follows: patient's orthopedic surgeon injected monovisc into the patient's left knee to treat steoarthritis.Fives minutes after the inject, the patient experienced swelling and edema in the lips and throat.The patient took benadryl and the symptoms resolved after 90 minutes.There was no reported medical intervention required.Additional information was not provided upon solicitation.See h10 for the plant investigation.
|
|
Search Alerts/Recalls
|